tiprankstipranks
Trending News
More News >
AbbVie (DE:4AB)
XETRA:4AB
Germany Market

AbbVie (4AB) Technical Analysis

Compare
23 Followers

Summary of all the Indicators

Overall Consensus
Sell
4Bullish
4Neutral
14Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
AbbVie’s (4AB) Moving Averages Convergence Divergence (MACD) indicator is -0.30, suggesting AbbVie is a Buy.
AbbVie’s (4AB) 20-Day exponential moving average is 164.79, while AbbVie’s (4AB) share price is €161.6, making it a Sell.
AbbVie’s (4AB) 50-Day exponential moving average is 166.96, while AbbVie’s (4AB) share price is €161.6, making it a Sell.

AbbVie (4AB) Pivot Points

Jun 21, 2025, 07:02 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
159.40
160.80
162.00
163.40
164.60
166.00
167.20
Fibonacci
160.80
161.79
162.41
163.40
164.39
165.01
166.00
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbbVie (4AB) Moving Averages

Jun 21, 2025, 07:02 AM
Period
Simple
Exponential
MA5
164.60Sell
164.03Sell
MA10
165.52Sell
164.65Sell
MA20
164.43Sell
164.79Sell
MA50
162.90Sell
166.96Sell
MA100
175.11Sell
169.65Sell
MA200
172.04Sell
168.44Sell
AbbVie’s (4AB) 10-Day exponential moving average is 164.65, while AbbVie’s (4AB) share price is €161.6, making it a Sell.
AbbVie’s (4AB) 100-Day exponential moving average is 169.65, while AbbVie’s (4AB) share price is €161.6, making it a Sell.
AbbVie’s (4AB) stock price is €161.6 and AbbVie’s (4AB) 50-day simple moving average is 162.90, creating a Sell signal.
AbbVie’s (4AB) stock price is €161.6 and AbbVie’s (4AB) 100-day simple moving average is 175.11, creating a Sell signal.
AbbVie’s (4AB) stock price is €161.6 and AbbVie’s (4AB) 200-day simple moving average is 172.04, creating a Sell signal.

AbbVie (4AB) Technical Indicators

Jun 21, 2025, 07:02 AM
Name
Value
Implied Action
RSI (14)
43.08
Neutral
STOCH (9,6)
24.07
Neutral
STOCHRSI (14)
32.70
Neutral
MACD (12,26)
-0.30
Buy
ADX (14)
13.19
Buy
Williams %R
-78.38
Buy
CCI (14)
-106.41
Buy
ATR (14)
2.98
-
Ultimate Oscillator
59.97
Neutral
ROC
-0.61
Sell
AbbVie’s (4AB) Relative Strength Index (RSI) is 43.08, creating a Neutral signal.
AbbVie’s (4AB) Trend Strength Indicator (ADX) is 13.19, creating a Buy signal.
AbbVie’s (4AB) Commodity Channel Index (CCI) is -106.41, creating a Buy signal.
AbbVie’s (4AB) Price Rate of Change (ROC) is -0.61, creating a Sell signal.

FAQ

Is 4AB a Buy, Hold, or Sell?
Based on 4AB’s technical indicators, 4AB is a Sell.
    What is 4AB’s RSI (14)?
    4AB’s RSI (14) is 43.08, which suggests 4AB is a Neutral.
      What is 4AB’s MACD?
      4AB’s MACD is -0.30, which suggests 4AB is a Buy.
        What is 4AB’s 5-day moving average?
        4AB’s 5-day moving average is 164.60, which suggests 4AB is a Sell.
          What is 4AB’s 20-day moving average?
          4AB 20-day moving average is 164.43, which suggests 4AB is a Sell.
            What is 4AB’s 50-day moving average?
            4AB’s 50-day moving average is 162.90, which suggests 4AB is a Sell.
              What is 4AB’s 200-day moving average?
              4AB’s 200-day moving average is 172.04, which suggests 4AB is a Sell.
                What is 4AB’s Williams % R (14)?
                4AB’s Williams % R (14) is -78.38, which suggests 4AB is a Buy.
                  What is 4AB’s CCI (14)?
                  4AB’s CCI (14) is -106.41, which suggests 4AB is a Buy.
                    What is the share price of AbbVie?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis